ZUG, Switzerland, October 11 /PRNewswire/ -- The young Swiss biotech enterprise AMVAC AG has gained reinforcement from Prof. Michel Klein, one of the world's most renowned vaccine specialists. Prof. Klein, who was formerly Vice President of Science & Technology of the Aventis-Pasteur Group, will immediately assume directorship of the scientific sector of vaccine development at AMVAC AG. This distinguished vaccinologist has access to an outstanding network across one of the greatest growth markets and will make a critical contribution in AMVAC AG's product research and development. Along with the vaccine against bacterial vaginosis already approved in Hungary, Klein is focusing on the further development of a vaccine against prostate enlargement, for which the performance of a clinical phase III study has been approved. In addition, AMVAC AG is preparing new projects for indications unnamed until now. Official statements on more new projects in the pharmaceutical industry will be released in the coming weeks.
Melinda Karpati, CEO of AMVAC, AG says, "Being able to win Prof. Michel
Klein is a great success for us and affirms not only AMVAC AG's executive?
direction, but also the continued recognition that we have come to know on
the part of experienced experts in the field of vaccine development. His
global network and the tremendous experience that Prof. Michel Klein brings
to AMVAC AG will help us develop novel prophylactic and immunotherapeutic
products in the pharmaceutical industry. Our new CSO's 40-year career has
included numerous scientific publications, distinctions and groundbreaking
vaccine developments. He has developed the five-component acellular
pertussis vaccine currently on the market, brought vaccines against PIV-3,
RSV and flu to phase I/II trials, launched the cancer vaccine program of
Aventis-Pasteur and performed more than 40 trials with several prototypes
of prophylactic and therapeutic HIV vaccines in collaboration with the NIH,
|SOURCE AMVAG AG|
Copyright©2007 PR Newswire.
All rights reserved